GET DAILY SIGNALSUiPath (PATH) Reports Steady Q2 Growth While Advancing Its AI Strategy
Key Takeaways
- UiPath reported $410.26 million in revenue for the second quarter of fiscal 2027, up 13.4% year over year and ahead of consensus estimates.
- Non-GAAP earnings per share (EPS) came in at $0.15, in line with analyst expectations of $0.15.
- Annual recurring revenue (ARR) reached $1.94 billion, up 12.5% year over year, while net new ARR totaled $37 million.
- Adjusted operating income of $89.03 million (a 21.7% margin) beat analyst projections, underscoring improved profitability.
- Management raised full-year fiscal 2027 revenue guidance to roughly $1.79 billion at the midpoint.
Putting the Results in Context
UiPath (PATH) stands out as a key player in enterprise automation and AI software, so its quarterly updates serve as a useful gauge of broader spending trends in automation and agentic AI. The second quarter of fiscal 2027, ending July 31, 2026, gives investors an updated look at whether the company can maintain momentum while shifting focus toward AI agents and orchestration. After achieving its first full-year GAAP profitability, this report helps test demand strength, ARR trends, and margin progress in a competitive software environment. The market’s measured response reflects how investors are assessing UiPath (PATH)’s longer-term positioning.
Breaking Down the Quarterly Numbers
In the second quarter of fiscal 2027, UiPath (PATH) posted total revenue of $410.26 million, marking a 13.4% rise from $361.73 million a year earlier and surpassing the consensus estimate of about $397.6 million. Non-GAAP EPS landed at $0.15, matching analyst forecasts and holding steady from the prior-year quarter. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Annual recurring revenue (ARR) climbed to $1.94 billion, reflecting 12.5% year-over-year growth, with net new ARR coming in at $37 million. The dollar-based net retention rate remained at 109%. Adjusted operating income reached $89.03 million, or a 21.7% margin, which topped the roughly $75.2 million analysts had projected. Management set third-quarter fiscal 2027 revenue guidance in the range of $440 million to $445 million and lifted full-year fiscal 2027 revenue guidance to approximately $1.79 billion at the midpoint.
How the Market Responded
Shares of UiPath (PATH) showed a relatively subdued reaction, closing near $18.24 and rising only modestly in after-hours trading. The results beat on revenue yet delivered EPS exactly in line with expectations. Over the past twelve months the stock has posted strong gains, leaving investors constructive but mindful of the need for continued execution. The balanced price action suggests investors weighed the revenue and adjusted operating income beats against softer free cash flow margin and a modest billings shortfall.
What to Watch Going Forward
Guidance for the coming periods points to mid-to-high single-digit revenue growth in the near term, a pace that will draw close attention. The company’s expansion into agentic AI and process orchestration forms the core growth story, so updates on enterprise uptake of these newer offerings will be important signals.
Margin performance is another area of focus. Although adjusted operating income exceeded expectations this quarter, free cash flow margin fell noticeably from the prior period, and investors will track whether profitability improvements lead to stronger cash generation over time.
ARR growth and net new ARR remain the most direct measures of demand resilience. Any stabilization or pickup in net new ARR, paired with steady dollar-based net retention, would likely bolster confidence in the shift toward AI-driven automation. On the other hand, further slowdowns in billings or retention could weigh on sentiment given the stock’s current valuation.
Integrating AI Tools Into My Research Process
When analyzing results like these, I often turn to Tickeron’s AI-powered tools to cross-check patterns and compare UiPath (PATH) against peers. One platform I find particularly useful is the AI Screener, which lets me quickly filter for technical setups, fundamentals, and industry trends. It helps surface ideas more efficiently than manual reviews and has become a regular part of how I evaluate names in the software space.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PATH's RSI Oscillator ascends from oversold territory
The RSI Indicator for PATH moved out of oversold territory on September 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 236 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 126 of 173 cases where PATH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 58 cases where PATH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In 65 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for PATH turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 34 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
PATH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. PATH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.512) is normal, around the industry mean (16.526). P/E Ratio (19.597) is within average values for comparable stocks, (57.809). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.287) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (103.889).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement